BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29928948)

  • 21. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens.
    Shinde A; Yang D; Frankel P; Liu A; Han C; Del Vecchio B; Schultheiss T; Cheng J; Li R; Kim D; Radany EH; Hui S; Somlo G; Rosenthal J; Stein A; Forman S; Wong JYC
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1025-1033. PubMed ID: 31421151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Deeg HJ; Stevens EA; Salit RB; Ermoian RP; Fang M; Gyurkocza B; Sorror ML; Fatobene G; Baumgart J; Burroughs LM; Delaney C; Doney K; Egan DN; Flowers MED; Milano F; Radich JP; Scott BL; Sickle EJ; Wood BL; Yeung C; Storer BE
    Biol Blood Marrow Transplant; 2018 May; 24(5):956-963. PubMed ID: 29274396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
    Hegenbart U; Niederwieser D; Sandmaier BM; Maris MB; Shizuru JA; Greinix H; Cordonnier C; Rio B; Gratwohl A; Lange T; Al-Ali H; Storer B; Maloney D; McSweeney P; Chauncey T; Agura E; Bruno B; Maziarz RT; Petersen F; Storb R
    J Clin Oncol; 2006 Jan; 24(3):444-53. PubMed ID: 16344316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.
    Mitsuhashi K; Kako S; Shigematsu A; Atsuta Y; Doki N; Fukuda T; Kanamori H; Onizuka M; Takahashi S; Ozawa Y; Kurokawa M; Inoue Y; Nagamura-Inoue T; Morishima Y; Mizuta S; Tanaka J;
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2194-2200. PubMed ID: 27638362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients.
    Donato V; Iacari V; Zurlo A; Capua A; Tombolini V; Banelli E; Enrici RM; De Felice C; Giacco G; Iori AP; Arcese W; Biagini C
    Radiother Oncol; 1998 Sep; 48(3):267-76. PubMed ID: 9925246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.
    Mikell JL; Waller EK; Switchenko JM; Rangaraju S; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khoury HJ; Khan MK
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):360-9. PubMed ID: 24837891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML.
    Holtick U; Herling M; Pflug N; Chakupurakal G; Leitzke S; Wolf D; Hallek M; Scheid C; Chemnitz JM
    Ann Hematol; 2017 Mar; 96(3):479-487. PubMed ID: 27909887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation.
    Czyz A; Labopin M; Giebel S; Socié G; Apperley J; Volin L; Reményi P; Yakoub-Agha I; Orchard K; Michallet M; Stuhler G; Chaganti S; Murray M; Aljurf M; Bloor A; Passweg J; Finke J; Mohty M; Nagler A
    Am J Hematol; 2018 Jun; 93(6):778-785. PubMed ID: 29574915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients.
    Girinsky T; Socie G; Ammarguellat H; Cosset JM; Briot E; Bridier A; Gluckman E
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):821-4. PubMed ID: 7960983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
    Pavlů J; Labopin M; Zoellner AK; Sakellari I; Stelljes M; Finke J; Fanin R; Stuhler G; Afanasyev BV; Bloor AJ; Anagnostopoulos A; Mohty M; Giebel S; Nagler A
    Cancer; 2017 Jun; 123(11):1965-1970. PubMed ID: 28211939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
    Decroocq J; Itzykson R; Vigouroux S; Michallet M; Yakoub-Agha I; Huynh A; Beckerich F; Suarez F; Chevallier P; Nguyen-Quoc S; Ledoux MP; Clement L; Hicheri Y; Guillerm G; Cornillon J; Contentin N; Carre M; Maillard N; Mercier M; Mohty M; Beguin Y; Bourhis JH; Charbonnier A; Dauriac C; Bay JO; Blaise D; Deconinck E; Jubert C; Raus N; Peffault de Latour R; Dhedin N
    Am J Hematol; 2018 Mar; 93(3):416-423. PubMed ID: 29226497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
    Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S
    Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Stelljes M; Bornhauser M; Kroger M; Beyer J; Sauerland MC; Heinecke A; Berning B; Scheffold C; Silling G; Buchner T; Neubauer A; Fauser AA; Ehninger G; Berdel WE; Kienast J;
    Blood; 2005 Nov; 106(9):3314-21. PubMed ID: 16020510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
    Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA
    Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
    Marks DI; Forman SJ; Blume KG; Pérez WS; Weisdorf DJ; Keating A; Gale RP; Cairo MS; Copelan EA; Horan JT; Lazarus HM; Litzow MR; McCarthy PL; Schultz KR; Smith DD; Trigg ME; Zhang MJ; Horowitz MM
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):438-53. PubMed ID: 16545728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT).
    Corvò R; Lamparelli T; Bruno B; Barra S; Van Lint MT; Vitale V; Bacigalupo A
    Bone Marrow Transplant; 2002 Dec; 30(11):717-23. PubMed ID: 12439693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.